PAN: Neurofibromatosis (Premium Assistance)

Funded
About
The PAN: Neurofibromatosis (Premium Assistance) program provides financial aid to individuals receiving treatment for neurofibromatosis. This program offers premium assistance for a wide range of medications, including Beleodaq, Egrifta SV, Forteo, and many others. Designed to support those with health insurance and covered medications, the PAN: Neurofibromatosis program aims to ease the financial burden of drug costs and enhance access to essential treatments.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
$4700 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note the following:
1. This fund may cover offlabel drugs
2. This fund is for premium assistance only
Patients can either call (18663167263) or apply through selfservice patient portal
Provided patient completes application on self service portal or over the phone, eligibility determination takes less than one minute
Portal/representative will provide enrollment dates, the patient's PAN I.D. number and the available grant balance, allowing for medications to be dispensed
Patients will also receive approval letter and plastic pharmacy card within one week (provider will also receive letter)
Assistance begins on approval date and continues for 12 months
During initial eligibility period, eligible expenses incurred up to 90 days prior to approval date may also be submitted for reimbursement
All eligible expenses must be submitted within 120 days of the eligibility end date
Payment can be made to the patient, physician, pharmacy or health care provider
Patients are eligible for renewal at the end of their eligibility period if funds are available
Foundation will send a renewal application automatically if the program is accepting renewal patients
Patient may apply for a second grant during their eligibility period subject to availability of funding
Diagnosis Codes: ICD10: Q85.00, Q85.01, Q85.02, Q85.03, Q85.09, Q85.89
Other Programs

Assistance Fund: Hypophosphatasia (HPP)

Commercially Insured
Medicare / Medicaid

CancerCare: Bone Metastases

Medicare / Medicaid
Other Tools for Miacalcin